EMA-HMA Biosimilar Interchangeability Statement Offers ‘Unity And Clarity’ For Europe

Provides Foundation For Uptake Ahead Of Upcoming EU Pharmaceutical Legislation Reform

 
• By David Wallace
  
Isabell Remus Speaking At 18th Biosimilar Medicines Conference
Isabell Remus says the EMA-HMA statement brought “relief and joy” • Source: Medicines for Europe
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products